Applied Therapeutics Inc
NASDAQ:APLT
Cash Flow Statement
Cash Flow Statement
Applied Therapeutics Inc
| Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||
| Net Income |
(12)
|
(22)
|
(46)
|
(49)
|
(69)
|
(88)
|
(94)
|
(106)
|
(104)
|
(102)
|
(106)
|
(105)
|
(105)
|
(95)
|
(83)
|
(70)
|
(73)
|
(97)
|
(120)
|
(194)
|
(161)
|
(187)
|
(106)
|
(44)
|
(68)
|
(18)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Stock-Based Compensation |
4
|
5
|
6
|
7
|
6
|
7
|
8
|
10
|
11
|
11
|
11
|
10
|
10
|
10
|
10
|
10
|
9
|
8
|
7
|
8
|
8
|
8
|
13
|
15
|
15
|
14
|
|
| Other Non-Cash Items |
2
|
3
|
6
|
7
|
6
|
9
|
11
|
14
|
15
|
15
|
16
|
16
|
19
|
19
|
14
|
12
|
20
|
46
|
66
|
130
|
93
|
107
|
19
|
(49)
|
(27)
|
(67)
|
|
| Change in Working Capital |
(3)
|
(1)
|
3
|
(6)
|
8
|
11
|
5
|
11
|
(3)
|
0
|
(1)
|
(4)
|
(0)
|
(13)
|
(9)
|
(4)
|
(6)
|
(4)
|
(1)
|
(3)
|
(6)
|
(1)
|
3
|
(2)
|
4
|
(2)
|
|
| Cash from Operating Activities |
(13)
N/A
|
(21)
-61%
|
(36)
-76%
|
(48)
-33%
|
(55)
-14%
|
(68)
-23%
|
(78)
-15%
|
(82)
-4%
|
(92)
-12%
|
(87)
+5%
|
(91)
-5%
|
(93)
-2%
|
(85)
+8%
|
(89)
-4%
|
(78)
+12%
|
(61)
+22%
|
(59)
+3%
|
(54)
+8%
|
(55)
-2%
|
(67)
-22%
|
(74)
-10%
|
(82)
-11%
|
(84)
-3%
|
(94)
-12%
|
(91)
+3%
|
(87)
+5%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||
| Other Items |
0
|
(20)
|
(20)
|
(62)
|
(38)
|
(48)
|
(19)
|
(2)
|
(10)
|
29
|
12
|
47
|
35
|
32
|
13
|
18
|
12
|
7
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
(20)
N/A
|
(20)
-1%
|
(62)
-208%
|
(38)
+39%
|
(48)
-27%
|
(19)
+59%
|
(2)
+88%
|
(10)
-299%
|
29
N/A
|
12
-57%
|
47
+275%
|
35
-24%
|
32
-10%
|
13
-59%
|
18
+33%
|
12
-32%
|
7
-42%
|
14
+99%
|
0
-100%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||
| Net Issuance of Common Stock |
40
|
41
|
40
|
171
|
136
|
136
|
136
|
76
|
75
|
75
|
75
|
0
|
28
|
28
|
28
|
0
|
28
|
45
|
75
|
191
|
161
|
144
|
114
|
(2)
|
0
|
0
|
|
| Net Issuance of Debt |
(6)
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(3)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
0
|
(0)
|
(0)
|
|
| Other |
(2)
|
(2)
|
16
|
16
|
17
|
17
|
3
|
0
|
8
|
8
|
4
|
0
|
3
|
3
|
3
|
0
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Cash from Financing Activities |
33
N/A
|
33
-1%
|
56
+73%
|
188
+233%
|
152
-19%
|
152
-1%
|
136
-10%
|
76
-45%
|
79
+4%
|
79
+0%
|
75
-5%
|
0
-99%
|
27
+6 114%
|
27
+0%
|
28
+1%
|
28
+1%
|
27
-4%
|
44
+66%
|
75
+69%
|
191
+156%
|
160
-16%
|
143
-10%
|
114
-21%
|
(2)
N/A
|
(0)
+88%
|
(0)
-38%
|
|
| Change in Cash | |||||||||||||||||||||||||||
| Net Change in Cash |
20
N/A
|
(8)
N/A
|
0
N/A
|
78
+77 710%
|
60
-23%
|
36
-40%
|
39
+8%
|
(8)
N/A
|
(22)
-166%
|
22
N/A
|
(4)
N/A
|
(46)
-1 181%
|
(23)
+50%
|
(30)
-31%
|
(37)
-25%
|
(15)
+59%
|
(20)
-31%
|
(3)
+85%
|
33
N/A
|
124
+272%
|
86
-30%
|
61
-29%
|
30
-52%
|
(96)
N/A
|
(91)
+4%
|
(87)
+5%
|
|
| Free Cash Flow | |||||||||||||||||||||||||||
| Free Cash Flow |
(13)
N/A
|
(21)
-61%
|
(36)
-76%
|
(48)
-33%
|
(55)
-14%
|
(68)
-23%
|
(78)
-15%
|
(82)
-4%
|
(92)
-12%
|
(87)
+5%
|
(91)
-5%
|
(93)
-2%
|
(85)
+8%
|
(89)
-4%
|
(78)
+12%
|
(61)
+22%
|
(59)
+3%
|
(54)
+8%
|
(55)
-2%
|
(67)
-22%
|
(74)
-10%
|
(82)
-11%
|
(84)
-3%
|
(94)
-12%
|
(91)
+3%
|
(87)
+5%
|
|